Panel: Searching for Novel Therapeutic Targets – Addressing Developmental Challenges for New Drug Candidates in Wet AMD & DME
Time: 11:10 am
day: Day Two
• Discussions around the challenges of investigating unique treatment mechanistic pathways in wet AMD and DME, which can improve on existing anti-VEGF approaches
• How does the distinctive disease progression pathways of both wet AMD and DME present the opportunity for new target discovery?
• What are the key development bottlenecks in target identification and demonstrating proof-of-concept, right through to the planning the clinical evidence which will need to be generated to address any regulatory questions which could arise?